Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZMAT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CYHR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PADI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIK5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINGO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C20orf181 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC00557 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GNT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FABP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6837 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3GL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAAP20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMSB15B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on